MiMedx Group, Inc
MDXG Real Time Price USDRecent trades of MDXG by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Tom Malinowski House / D | Sale $15,001 - $50,000 | May 30, 2019 |
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by MDXG's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$20,000 Jul 09, 2025 Issue: Medicare/Medicaid
-
$30,000 May 06, 2025 Issue: Medicare/Medicaid
-
$20,000 Apr 16, 2025 Issue: Medicare/Medicaid
-
$30,000 Feb 05, 2025 Issue: Medicare/Medicaid
-
$20,000 Jan 10, 2025 Issue: Medicare/Medicaid
-
$30,000 Nov 08, 2024 Issue: Medicare/Medicaid
-
$20,000 Oct 18, 2024 Issue: Medicare/Medicaid
-
$30,000 Aug 06, 2024 Issue: Medicare/Medicaid
-
$20,000 Jul 19, 2024 Issue: Medicare/Medicaid
-
$20,000 Apr 17, 2024 Issue: Medicare/Medicaid
-
$20,000 Jan 22, 2024 Issue: Medicare/Medicaid
-
$20,000 Oct 18, 2023 Issue: Medicare/Medicaid
-
$50,000 Jul 18, 2023 Issue: Medicare/Medicaid
-
$50,000 Jan 18, 2023 Issue: Medicare/Medicaid
-
$50,000 Oct 19, 2022 Issue: Medicare/Medicaid
-
$50,000 Jul 19, 2022 Issue: Medicare/Medicaid
-
$30,000 Apr 19, 2022 Issue: Medicare/Medicaid
-
$30,000 Jan 19, 2022 Issue: Medicare/Medicaid
-
$30,000 Oct 19, 2021 Issue: Medicare/Medicaid
-
$30,000 Jul 20, 2021 Issue: Medicare/Medicaid
-
$35,000 Apr 20, 2021 Issue: Medicare/Medicaid
-
$20,000 Jan 20, 2021 Issue: Medicare/Medicaid
Estimated quarterly lobbying spending
MDXG Revenue by Segment or Geography
New patents grants
-
Patent Title: Reinforced placental tissue grafts and methods of making and using the same Jan. 28, 2025
-
Patent Title: Cross-linked dehydrated placental tissue grafts and methods for making and using the same Sep. 10, 2024
-
Patent Title: Micronized placental compositions comprising a chelator Sep. 03, 2024
-
Patent Title: Collagen and micronized placental tissue compositions and methods of making and using the same Aug. 27, 2024
-
Patent Title: Micronized placental tissue compositions and methods of making and using the same Mar. 19, 2024
-
Patent Title: Compositions and methods of treatment with amniotic fluid Jan. 09, 2024
-
Patent Title: Placental tissue grafts and improved methods of preparing and using the same Sep. 12, 2023
-
Patent Title: Non-surgical, localized delivery of compositions for placental growth factors Jul. 04, 2023
-
Patent Title: Methods for treating cardiac conditions May. 16, 2023
-
Patent Title: Tissue grafts composed of micronized placental tissue and methods of making and using the same Mar. 21, 2023
-
Patent Title: Laminated tissue grafts composed of wharton's jelly and methods of making and using the same Mar. 14, 2023
-
Patent Title: Methods of making collagen fiber medical constructs and related medical constructs, including patches Feb. 28, 2023
-
Patent Title: Collagen constructs and methods of making the same Feb. 21, 2023
-
Patent Title: Placental tissue grafts and methods of preparing and using the same Nov. 22, 2022
-
Patent Title: Isolated placental stem cell recruiting factors Nov. 15, 2022
-
Patent Title: Placental tissue component compositions for treatment of skin defects and methods using same Jul. 26, 2022
-
Patent Title: Molded placental tissue compositions and methods of making and using the same Jul. 19, 2022
-
Patent Title: Placental tissue grafts modified with a cross-linking agent and methods of making and using the same May. 24, 2022
-
Patent Title: Micronized placental tissue compositions and methods of making and using the same Feb. 01, 2022
-
Patent Title: Micronized placental tissue compositions and methods of making and using the same Jan. 11, 2022
-
Patent Title: Micronized placental tissue compositions and methods of making and using the same Aug. 31, 2021
-
Patent Title: Placental tissue composition for for treating cardiac tissue damage May. 11, 2021
-
Patent Title: Compositions and methods of treatment with amniotic fluid Mar. 30, 2021
-
Patent Title: Synthetic collagen threads for cosmetic uses including skin wrinkle treatments and associated methods Mar. 02, 2021
-
Patent Title: Placental tissue grafts and improved methods of preparing and using the same Dec. 29, 2020
-
Patent Title: Tissue grafts modified with a cross-linking agent and method of making and using the same Dec. 22, 2020
-
Patent Title: Tissue grafts modified with a cross-linking agent and method of making and using the same Dec. 22, 2020
-
Patent Title: Reinforced placental tissue grafts and methods of making and using the same Dec. 08, 2020
-
Patent Title: Placental tissue component compositions for treatment of skin defects and methods using same Dec. 01, 2020
-
Patent Title: Method for inducing angiogenesis Nov. 24, 2020
-
Patent Title: Collagen and micronized placental tissue compositions and methods of making and using the same Aug. 11, 2020
-
Patent Title: Kits and materials for implantable collagen devices Jun. 23, 2020
-
Patent Title: Collagen fiber ribbons with integrated fixation sutures and methods of making the same May. 19, 2020
-
Patent Title: Non-surgical, localized delivery of compositions for placental growth factors Dec. 31, 2019
-
Patent Title: Micronized placental compositions comprising a chelator Oct. 22, 2019
-
Patent Title: Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using the same Oct. 15, 2019
-
Patent Title: Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent Oct. 15, 2019
-
Patent Title: Placental tissue grafts and improved methods of preparing and using the same Sep. 10, 2019
-
Patent Title: Micronized placental tissue compositions and methods of making and using the same Aug. 13, 2019
-
Patent Title: Laminated tissue grafts composed of wharton's jelly and methods of making and using the same Jul. 16, 2019
-
Patent Title: Ndga polymers and metal complexes thereof Jul. 02, 2019
-
Patent Title: Micronized wharton's jelly Jun. 04, 2019
-
Patent Title: Biostaples suitable for wrist, hand and other ligament replacements or repairs Apr. 16, 2019
-
Patent Title: Methods of making collagen fiber medical constructs and related medical constructs, including nerve guides and patches Mar. 26, 2019
-
Patent Title: Tissue grafts modified with a cross-linking agent and method of making and using the same Mar. 19, 2019
-
Patent Title: Isolated placental stem cell recruiting factors Feb. 19, 2019
-
Patent Title: Cross-linked collagen comprising metallic anticancer agents Dec. 25, 2018
-
Patent Title: Medical constructs of twisted lengths of collagen fibers and methods of making same Dec. 11, 2018
-
Patent Title: Fenestration kits for making fenestrated placental tissue allografts and methods of using the same Dec. 04, 2018
-
Patent Title: Methods for treating cardiac conditions Oct. 30, 2018
Federal grants, loans, and purchases
- $10,380 2024-11-08 00:00:00 Agency: Department of Veterans Affairs
- $14,942 2024-08-27 00:00:00 Agency: Department of Veterans Affairs
- $2,500 2023-11-09 00:00:00 Agency: Department of Veterans Affairs
- $0 2023-11-06 00:00:00 Agency: Department of Veterans Affairs
- $0 2023-07-10 00:00:00 Agency: Department of Veterans Affairs
- $10,230 2023-04-10 00:00:00 Agency: Department of Veterans Affairs
- $26,740 2023-02-21 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $20,055 2023-01-23 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $24,600 2022-08-12 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
Estimated quarterly amount awarded from public contracts
Recent insights relating to MDXG
Recent picks made for MDXG stock on CNBC
ETFs with the largest estimated holdings in MDXG
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $MDXG stock a Buy, Sell, or Hold?
- What is the price target for $MDXG stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $MDXG stock?
- Who owns the most shares of $MDXG stock?
- What funds own $MDXG stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view MDXG Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.